Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Wednesday 03 October 2018 12:24 am  |  Updated:  Tuesday 21 May 2019 4:25 pm

City Moves for 3 October 2018 – who’s switching jobs at Healx, WorldRemit and Audere Solutions?

By: Francesca Washtell

Add as a preferred source on Google

NULL

Today's City Moves cover health, research and FX. Take a look at these movers and shakers:

Healx

Healx, the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, today announced the appointment of Kate Hilyard as chief operating officer (COO). A senior pharma executive, with extensive drug discovery expertise, Kate’s appointment underlines Healx’s mission to combine deep pharmacological expertise with artificial intelligence (AI) and active patient engagement to give sufferers of rare disease a better quality of life. At Healx, Kate will be lead strategy implementation to drive business growth enabling Healx to deliver rare disease treatments at scale through AI and cutting-edge technologies. Her industry experience adds to that of co-founder Dr David Brown, the inventor of Viagra and ex-global head of drug discovery at Roche, and the Healx drug discovery team.

WorldRemit

Gregory Thwaites joins WorldRemit as research director from the Bank of England. This is a newly created position in which Greg will look at macro trends impacting remittances, produce proprietary research to support our growth and buttress WorldRemit’s narrative ahead of a future initial public offering. Greg spent 17 years at the Bank of England as a senior economist, and also teaches at LSE Centre for Macroeconomics. He has a broad theoretical and empirical research interests in remittances and fintech in a development context, and the macroeconomics of demographic and structural change, macroeconomic policy, financial stability, inequality and distribution.

Audere Solutions

Audere Solutions, the London-based independent foreign exchange risk management consultancy, is pleased to announce the appointment of Stuart Pitfield as managing director. Stuart will be responsible for managing the company’s rapidly expanding client footprint and sales growth. Since 2007, Stuart has been managing director of FX sales for BNY Mellon, the worldwide banking and financial services company. In 2015, he stepped up to manage BNY Mellon’s entire EMEA FX sales business. He was also responsible for growing the business and its complexities – managing over 150 institutional clients located in six countries across the EMEA region. Under Stuart’s leadership, the team delivered consistent year on year growth despite significant challenges experienced across the industry. After 25 years in the FX sales industry Stuart is keen for a new challenge and the opportunity to use his experience and knowledge of the foreign exchange industry in a dynamic and fast growing company.

[custom id="162"]

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money

Categories

  • Personal Development

Related Topics

  • City Moves

Trending Articles

  • Exclusive: Big Four giant KPMG to cut more jobs

  • Music tycoon Simon Cowell sued by prominent City lawyer

  • The former African gold miner taking on the billionaire Issa brothers

  • Tesco ‘in talks’ to exit eastern Europe

  • As it happened: FTSE 100 slump as oil soars; Trump says Iran will be ‘hit hard’ tonight

More from City PM

  • IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

    Business Wire
  • True Expands Financial Services Footprint with Jeremy Zeman as Head of Consumer & Commercial Banking

    Business Wire
  • IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • ‘Act now’: AI models capable of attacks on governments months away, Five Eyes warn

    Tech
    GettyImages 158774123 showcases a relevant business meeting scene, highlighting diverse professionals engaged in discussion.
  • Chariot Capital Group Acquires Laser Clinics UK

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • ‘Clients pay for expertise, not process’ – Grant Thornton rolls out Anthropic AI

    Accountancy
    Grant Thornton

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook